Loading...
Novel agents in chronic lymphocytic leukemia
The advent of novel small-molecule inhibitors has transformed the treatment approaches for patients with chronic lymphocytic leukemia (CLL). These therapies are becoming increasingly used in patients with relapsed disease, patients with 17p deletion, and, as of recently, also in the frontline settin...
Na minha lista:
| Udgivet i: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142499/ https://ncbi.nlm.nih.gov/pubmed/27913472 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|